Black Diamond Therapeutics, Inc. (BDTX) Revenue (2025)
Black Diamond Therapeutics (BDTX) posted Revenue of $70.0 million for Q1 2025.
Black Diamond Therapeutics, Inc. (BDTX) Revenue (2025) Analysis & Trends
Black Diamond Therapeutics (BDTX) has reported Revenue for 1 consecutive years, with $70.0 million the latest figure, recorded in Q1 2025.
- Revenue for Q1 2025 came in at $70.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $70.0 million (changed N/A YoY), and the FY2025 annual result was $70.0 million, changed N/A from the prior year.
- Revenue was $70.0 million for Q1 2025 at Black Diamond Therapeutics.
- Over five years, Revenue peaked at $70.0 million in Q1 2025 and troughed at $70.0 million in Q1 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 70.00 Mn |